HBOT for Tinnitus: Does It Help, and Can It Make It Worse?

Tinnitus is the ringing, buzzing, or hissing you hear when no outside sound is making it. People with bad tinnitus often ask whether hyperbaric oxygen therapy (HBOT) can quiet it down. The honest answer is narrow: there is a small, early window where HBOT may help, but for most people with long-standing ringing, the evidence does not support it, and in a few cases the therapy itself can briefly make ear symptoms worse.

This page walks through what the research actually shows, where the hope comes from, and where the hype runs ahead of the facts. We will keep it plain and we will not oversell it.

The Short Answer

For chronic, standalone tinnitus that has been present for months or years, HBOT is not supported by good evidence and is not a recommended treatment.

For tinnitus that shows up alongside sudden hearing loss and is treated early (within the first couple of weeks), there is weak, low-quality evidence of a possible benefit, mostly on the hearing side rather than the ringing itself.

That is the whole story in two sentences. Everything below explains why.

Why Tinnitus and Sudden Hearing Loss Get Lumped Together

Most of the HBOT research on tinnitus did not study tinnitus on its own. It studied idiopathic sudden sensorineural hearing loss (ISSHL) — a fast, unexplained drop in hearing in one ear that often comes with a new ringing sound.

This matters. When you read that "HBOT helps tinnitus," it almost always traces back to studies of sudden hearing loss patients who also had tinnitus, not people whose only problem is ringing. Researchers measured hearing thresholds (in decibels) as the main outcome. Tinnitus was usually a secondary, harder-to-measure outcome.

So the evidence base is really about acute ear injury, not the everyday chronic ringing that drives most people to search for answers. Our companion page on HBOT for sudden sensorineural hearing loss covers that condition in depth.

What "idiopathic" means here

Idiopathic just means "we don't know the cause." Sudden hearing loss can come from a virus, a blood-flow problem in the inner ear, inflammation, or something never identified. Because the inner ear is fed by a tiny, fragile blood supply, doctors have long wondered whether flooding the body with oxygen could rescue struggling hair cells before they die. That idea is the mechanism rationale below.

Not all tinnitus is the same

It helps to know that "tinnitus" is a symptom, not one disease. Sorting it into rough buckets explains why HBOT might matter in one and not another:

• Acute tinnitus with sudden hearing loss. New ringing that appears in days, paired with a measurable drop in hearing. This is the only group HBOT research really touches, and even here the benefit is uncertain.
• Chronic subjective tinnitus. Ringing you have heard for months or years, often tied to age-related or noise-related hearing loss. This is the most common type and the one HBOT does not help.
• Pulsatile tinnitus. A whooshing that follows your heartbeat, sometimes pointing to a blood-vessel issue. This needs its own workup and is not an HBOT target.
• Tinnitus from a clear cause (earwax, an ear infection, a medication, jaw problems). Here you fix the cause; a chamber is beside the point.

When someone asks "does HBOT help tinnitus," the answer depends almost entirely on which bucket they fall into. The marketing rarely makes that distinction. The science does.

The Mechanism Rationale (Why Anyone Thought This Could Work)

HBOT means breathing 100% oxygen inside a pressurized chamber, usually at 2.0 to 2.4 times normal atmospheric pressure. Under pressure, far more oxygen dissolves directly into your blood plasma, not just the red blood cells. That raises oxygen levels in tissues that are normally hard to reach. You can read more in our overview of how HBOT works.

The inner ear theory goes like this:

• The cochlea (the hearing organ) has very high oxygen demand and a poor backup blood supply.
• After a sudden injury, the inner ear may be starved of oxygen even when the rest of the body is fine.
• HBOT could push extra oxygen into that starved tissue, keeping hair cells alive during the critical early days.
• Saving hair cells might preserve hearing — and, the hope went, calm the tinnitus that came with the injury.

The same high-oxygen mechanism is well documented for wound healing, where it reliably helps low-oxygen tissue. The leap to the inner ear is reasonable in theory. Theory is not proof, though, and the inner ear has turned out to be far less responsive than a chronic wound.

A key point: this rescue idea only makes sense early. Once hair cells are dead and tinnitus has settled in for the long haul, there is no starving tissue left to rescue. That is the single biggest reason HBOT does little for chronic ringing.

The gap between mechanism and result

This is worth sitting with, because it is the heart of the whole HBOT-for-tinnitus question. A plausible mechanism does not guarantee a real-world result. Researchers have repeatedly found inner-ear ideas that looked sound on paper but failed in trials. The cochlea is small, well-protected, and hard to study in living people, so we cannot directly watch HBOT "save" hair cells. We only have outcomes — hearing thresholds and patient-reported ringing — and those outcomes have stayed stubbornly modest.

There is also a measurement problem unique to tinnitus. Hearing loss is objective: you can measure decibels on an audiogram. Tinnitus is subjective: it depends on what the patient reports, which is influenced by mood, sleep, attention, and expectation. Anything a person believes will help — including sitting in an impressive high-tech chamber for an hour — can produce a temporary placebo dip in how loud the ringing feels. That makes weak, unblinded studies especially unreliable for tinnitus, and it is part of why Cochrane graded the evidence so cautiously.

The Actual Evidence

The most important document here is the Cochrane systematic review on hyperbaric oxygen for idiopathic sudden hearing loss and tinnitus. Cochrane reviews are the gold standard — they pool every decent trial and grade how trustworthy the result is.

The 2012 Cochrane review (an update of the 2007 version) reached a careful, sober conclusion:

• For people treated within 2 weeks of sudden hearing loss, HBOT produced a statistically significant improvement in hearing. The size of the benefit was modest, and the studies were small and at risk of bias.
• For chronic sudden hearing loss (treated 3 months or more after onset), there was no proven benefit.
• For tinnitus specifically, the review found the evidence too thin to draw any firm conclusion. The data did not show a reliable improvement in tinnitus.
• The authors graded the overall quality of evidence as low and called for better trials.

In plain terms: the strongest, most neutral review we have says HBOT might help hearing if you catch sudden loss early, but it does not establish that HBOT fixes tinnitus.

The evidence at a glance

The pattern is consistent across decades and across every level of evidence: early acute = maybe; chronic = no; tinnitus alone = unproven.

Reading the Cochrane numbers honestly

It is easy to misread a "statistically significant" result as a big deal. It is not the same thing. In the 2012 Cochrane review, the trials that fed the hearing result were small, mostly older, and carried a real risk of bias — meaning some were not properly blinded or randomized, which tends to inflate apparent benefits. The reviewers were explicit that the quality of the evidence was low, even where the average result favored HBOT.

A few specifics worth holding onto:

• The pooled hearing benefit was found only when treatment started within roughly 2 weeks of the sudden loss.
• The number of patients across all included trials was a few hundred — small by the standard needed to settle a question like this.
• The reviewers could not find enough usable tinnitus data to pool a tinnitus-specific result at all. That absence is telling.
• They called, plainly, for larger and better-designed trials before anyone treats the hearing finding as settled.

So when a clinic says "a Cochrane review supports HBOT," that is technically true for early hearing loss and false if stretched to chronic tinnitus. The same document that gives the hope also draws the limit.

Why newer reviews haven't changed the picture

You might expect a decade-plus of newer research to have resolved this. It hasn't, much. The 2026 review of hyperbaric treatment for sensorineural hearing loss reaches the same shape of conclusion: a defensible role in acute loss, no convincing case for chronic disease, and tinnitus benefit still unproven. The needle has not moved because the hard trial — large, blinded, tinnitus-focused, randomized — still has not been done. Until it is, the honest stance is caution, not enthusiasm.

What the guidelines say

The American Academy of Otolaryngology's Clinical Practice Guideline on Sudden Hearing Loss (2019 update) lists HBOT as an optional treatment that clinicians may offer for sudden sensorineural hearing loss, but only within about 2 weeks of onset (and as a salvage option up to roughly a month). Even there, it is framed as an option with limited evidence, not a must-do.

For chronic ringing, the 2025 VA/DOD Clinical Practice Guideline for tinnitus — one of the most thorough recent reviews of tinnitus care — does not endorse HBOT. The recommended path for bothersome chronic tinnitus is sound therapy, hearing aids when there is hearing loss, and cognitive behavioral therapy, not a hyperbaric chamber.

Can HBOT Make Tinnitus Worse?

Yes — this is a real and underdiscussed risk, and it is the part most marketing pages leave out.

The most common side effect of HBOT is middle ear barotrauma. As the chamber pressurizes, the air space behind your eardrum must equalize, the same way your ears pop on a plane or when diving. If you cannot clear your ears, the pressure difference stretches or injures the eardrum and middle ear.

A dedicated review, Middle Ear Barotrauma in Hyperbaric Oxygen Therapy, found that ear barotrauma is the single most frequent complication of HBOT, affecting a meaningful share of patients across studies. Symptoms include:

• Ear pain or fullness
• Muffled or reduced hearing
• A new or louder tinnitus in the affected ear
• In worse cases, fluid or bleeding behind the eardrum, or a perforation

So the irony is sharp: a therapy some people seek for tinnitus can, through ear barotrauma, cause new ear ringing — at least temporarily. Most barotrauma is mild and clears up, and good clinics screen for it and teach equalization techniques. But for someone whose only complaint is tinnitus, you are accepting a known ear-injury risk in exchange for an unproven benefit. That trade rarely makes sense.

Other HBOT risks (oxygen-related effects, sinus squeeze, claustrophobia, temporary vision changes) are covered in our guide to HBOT side effects and risks.

How clinics try to prevent ear injury

The risk is real but it is also managed. A good hyperbaric program will:

• Screen your ears before the first dive and ask about colds, allergies, and past ear surgery.
• Teach you equalization moves (swallowing, yawning, gentle nose-pinch-and-blow) and slow the pressurization rate if you struggle.
• Stop and re-check if you feel pain rather than pushing through it.
• In some cases place ear tubes (tiny pressure-equalizing tubes) for patients who cannot clear their ears at all.

If you do go forward, this screening is part of what you are paying for, and it is a fair question to ask any center directly: "How do you handle patients who can't equalize?" Our safety checklist lists more of the questions worth asking before you commit.

Who Might Reasonably Consider HBOT

Based on the evidence above, HBOT is most defensible for a narrow group:

• You have sudden sensorineural hearing loss (a fast, unexplained drop in hearing), not chronic ringing alone.
• The tinnitus arrived with that sudden hearing loss.
• You are early — ideally within 2 weeks of onset, and almost never useful beyond about a month.
• You are using it alongside standard care (steroids), not instead of it.
• You have healthy ears that can equalize pressure, lowering the barotrauma risk.

If that describes you, HBOT is a reasonable thing to discuss with an ENT and a hyperbaric physician — quickly, because the window is short. Our HBOT candidate eligibility guide can help you frame that conversation.

HBOT is an add-on, not a substitute

One thing the studies make clear: HBOT for sudden hearing loss was almost always used on top of standard care, not in place of it. The first-line treatment for sudden sensorineural hearing loss is corticosteroids — either by mouth or injected through the eardrum. Those steroids carry the strongest evidence for this condition.

So if you are in the early window, the path is not "HBOT instead of steroids." It is "steroids now, with HBOT considered as an additional option." Skipping the proven treatment to chase the unproven one would be a mistake. An ENT should lead this decision.

What a course looks like (and costs)

If you and your doctors decide HBOT is worth trying for acute hearing loss, expect a real commitment. A typical course runs 10 to 20 sessions or more, each lasting roughly 60 to 90 minutes, often daily across several weeks. The pressure is usually in the 2.0 to 2.4 ATA range.

Cost matters here. For sudden hearing loss, insurance coverage is inconsistent and for tinnitus alone it is essentially never covered, because tinnitus is not an approved indication. That can mean thousands of dollars out of pocket for a therapy with weak evidence. Our pages on HBOT cost walk through the real numbers so you go in with eyes open.

Why HBOT Is Not Recommended for Chronic Tinnitus

If your tinnitus has been around for months or years, here is why the chamber is the wrong tool:

1. No tissue left to rescue. The oxygen-rescue mechanism only applies during the acute injury window. Long-settled tinnitus involves changes in the brain's hearing pathways, not a starving cochlea.
2. The data are flat. The Cochrane reviews found no proven benefit for chronic cases, and tinnitus-specific results were never convincing even in acute studies.
3. Guidelines say no. The 2025 tinnitus guideline does not list HBOT among recommended treatments.
4. Real cost and real risk. A full HBOT course is dozens of sessions and thousands of dollars, usually not covered by insurance for tinnitus, and it carries a genuine ear-barotrauma risk.

Spending that time and money on an unproven therapy can also delay the treatments that actually help.

Better-Supported Alternatives for Chronic Tinnitus

Tinnitus is rarely "cured," but several approaches reliably reduce how much it bothers you. These have far stronger evidence than HBOT:

• Hearing aids, if you also have hearing loss — often the most effective single step.
• Sound therapy (maskers, white noise, hearing-aid masking features) to make the ringing less noticeable.
• Cognitive behavioral therapy (CBT), which has the strongest evidence for reducing tinnitus distress.
• Treating the underlying cause when there is one (earwax, medication side effects, blood pressure, ear infection).
• Protecting your hearing going forward to prevent it from worsening.

For a broader view of options beyond the chamber, see our roundup of alternatives to hyperbaric oxygen therapy.

The Bottom Line

HBOT is not a tinnitus treatment. It is, at best, an early, optional add-on for sudden hearing loss that happens to bring tinnitus with it — and even there, the benefit is modest, the evidence is low-quality, and the main payoff is on hearing, not the ringing. For chronic, standalone tinnitus, the evidence does not support it, the guidelines do not recommend it, and the therapy can occasionally make ear symptoms worse through barotrauma. Save your money and your ears for the approaches that actually work.

Frequently Asked Questions

Does hyperbaric oxygen therapy cure tinnitus?

No. There is no good evidence that HBOT cures or reliably reduces tinnitus. The Cochrane review found the data too weak to show a benefit for tinnitus, even in sudden hearing loss patients where most of the research was done.

Can HBOT help if my ringing started with sudden hearing loss?

Possibly, but only if you start early — within about 2 weeks. National guidelines list HBOT as an optional add-on for early sudden hearing loss. The likely benefit is on your hearing, not specifically the tinnitus, and it should be combined with standard steroid treatment.

Can hyperbaric oxygen make tinnitus worse?

Yes, temporarily. The most common HBOT side effect is middle ear barotrauma, which can cause new or louder ringing, ear pain, and muffled hearing if you cannot equalize chamber pressure. Most cases are mild and clear up.

Why isn't HBOT recommended for long-term tinnitus?

The oxygen-rescue mechanism only works during a brief injury window. Once tinnitus is chronic, there is no oxygen-starved tissue to save, the studies show no benefit, and the 2025 tinnitus guideline does not recommend it.

What works better than HBOT for tinnitus?

Hearing aids (if you have hearing loss), sound therapy, and cognitive behavioral therapy all have much stronger evidence for reducing tinnitus distress. Treating any underlying cause, like earwax or a medication side effect, also helps.

Medical disclaimer: This article is for general information only and is not medical advice. Talk to a qualified physician or ENT specialist before starting or stopping any treatment for tinnitus or hearing loss.